Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben

Details Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben

1997-09-25

1998-12-15

Jordan, Kimberly

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

A61K 3127

Patent

active

058497897

ABSTRACT:
The use of the compound I ##STR1## or its pharmaceutically utilizable salts for the propylaxis and treatment of the sequel of chronic reduced cerebral blood supply, in particular of stroke, and for the treatment of neurodegenerative disorders is claimed.

REFERENCES:
patent: 5384330 (1995-01-01), Dieter et al.
N/A, "Nerve cell protector comprising protein synthesis inhibitor--Protects against delayed nerve cell necrosis in treatment of cerebral ischaemia", abstract from WPI/Derwent, Publ. No. 92-030619. (1992).
Chatterjee, S.S., et al., "New 2H-1-benzopyran-2-one cpds. as NMDA antagonists--for treatment of chronic neuro-degenerative disorders, and as antironvulsants-antiepileptic agents", abstract from WPI/Derwent, Publ. No. 92-350553. (1992).
H. Herdon, "Meeting Highlights 17.sup.th Annual Meeting of the European Neuroscience Association--4-8 Sep. 1994, Vienna, Austria," Exp. Opin. Invest. Drugs, vol. 3, No. 12, 1994, pp. 1331-1332, XP 000653354.

Affiliated with

Also associated with

Rating

Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 4-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminoben will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1458465